Cargando…

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness

PURPOSE: To develop a robust and clinically applicable automated method for analyzing Dynamic Contrast Enhanced (DCE-) MRI of the prostate as a guide for targeted biopsies and treatments. MATERIALS AND METHODS: An unsupervised pattern recognition (PR) method was used to analyze prostate DCE-MRI from...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra, Nestor Andres, Pollack, Alan, Chinea, Felix M., Abramowitz, Matthew C., Marples, Brian, Munera, Felipe, Castillo, Rosa, Kryvenko, Oleksandr N., Punnen, Sanoj, Stoyanova, Radka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686056/
https://www.ncbi.nlm.nih.gov/pubmed/29177134
http://dx.doi.org/10.3389/fonc.2017.00259
_version_ 1783278706010095616
author Parra, Nestor Andres
Pollack, Alan
Chinea, Felix M.
Abramowitz, Matthew C.
Marples, Brian
Munera, Felipe
Castillo, Rosa
Kryvenko, Oleksandr N.
Punnen, Sanoj
Stoyanova, Radka
author_facet Parra, Nestor Andres
Pollack, Alan
Chinea, Felix M.
Abramowitz, Matthew C.
Marples, Brian
Munera, Felipe
Castillo, Rosa
Kryvenko, Oleksandr N.
Punnen, Sanoj
Stoyanova, Radka
author_sort Parra, Nestor Andres
collection PubMed
description PURPOSE: To develop a robust and clinically applicable automated method for analyzing Dynamic Contrast Enhanced (DCE-) MRI of the prostate as a guide for targeted biopsies and treatments. MATERIALS AND METHODS: An unsupervised pattern recognition (PR) method was used to analyze prostate DCE-MRI from 71 sequential radiotherapy patients. Identified regions of interest (ROIs) with increased perfusion were assigned either to the peripheral (PZ) or transition zone (TZ). Six quantitative features, associated with the washin and washout part of the weighted average DCE curve from the ROI, were calculated. The associations between the assigned DCE-scores and Gleason Score (GS) were investigated. A heatmap of tumor aggressiveness covering the entire prostate was generated and validated with histopathology from MRI-ultrasound fused (MRI-US) targeted biopsies. RESULTS: The volumes of the PR-identified ROI’s were significantly correlated with the highest GS from the biopsy session for each patient. Following normalization (and only after normalization) with gluteus maximus muscle’s DCE signal, the quantitative features in PZ were significantly correlated with GS. These correlations straightened in subset of patients with available MRI-US biopsies when GS from the individual biopsies were used. Area under the receiver operating characteristics curve for discrimination between indolent vs aggressive cancer for the significant quantitative features reached 0.88–0.95. When DCE-scores were calculated in normal appearing tissues, the features were highly discriminative for cancer vs no cancer both in PZ and TZ. The generated heatmap of tumor aggressiveness coincided with the location and GS of the MRI-US biopsies. CONCLUSION: A quantitative approach for DCE-MRI analysis was developed. The resultant map of aggressiveness correlated well with tumor location and GS and is applicable for integration in radiotherapy/radiology imaging software for clinical translation.
format Online
Article
Text
id pubmed-5686056
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56860562017-11-24 Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness Parra, Nestor Andres Pollack, Alan Chinea, Felix M. Abramowitz, Matthew C. Marples, Brian Munera, Felipe Castillo, Rosa Kryvenko, Oleksandr N. Punnen, Sanoj Stoyanova, Radka Front Oncol Oncology PURPOSE: To develop a robust and clinically applicable automated method for analyzing Dynamic Contrast Enhanced (DCE-) MRI of the prostate as a guide for targeted biopsies and treatments. MATERIALS AND METHODS: An unsupervised pattern recognition (PR) method was used to analyze prostate DCE-MRI from 71 sequential radiotherapy patients. Identified regions of interest (ROIs) with increased perfusion were assigned either to the peripheral (PZ) or transition zone (TZ). Six quantitative features, associated with the washin and washout part of the weighted average DCE curve from the ROI, were calculated. The associations between the assigned DCE-scores and Gleason Score (GS) were investigated. A heatmap of tumor aggressiveness covering the entire prostate was generated and validated with histopathology from MRI-ultrasound fused (MRI-US) targeted biopsies. RESULTS: The volumes of the PR-identified ROI’s were significantly correlated with the highest GS from the biopsy session for each patient. Following normalization (and only after normalization) with gluteus maximus muscle’s DCE signal, the quantitative features in PZ were significantly correlated with GS. These correlations straightened in subset of patients with available MRI-US biopsies when GS from the individual biopsies were used. Area under the receiver operating characteristics curve for discrimination between indolent vs aggressive cancer for the significant quantitative features reached 0.88–0.95. When DCE-scores were calculated in normal appearing tissues, the features were highly discriminative for cancer vs no cancer both in PZ and TZ. The generated heatmap of tumor aggressiveness coincided with the location and GS of the MRI-US biopsies. CONCLUSION: A quantitative approach for DCE-MRI analysis was developed. The resultant map of aggressiveness correlated well with tumor location and GS and is applicable for integration in radiotherapy/radiology imaging software for clinical translation. Frontiers Media S.A. 2017-11-10 /pmc/articles/PMC5686056/ /pubmed/29177134 http://dx.doi.org/10.3389/fonc.2017.00259 Text en Copyright © 2017 Parra, Pollack, Chinea, Abramowitz, Marples, Munera, Castillo, Kryvenko, Punnen and Stoyanova. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Parra, Nestor Andres
Pollack, Alan
Chinea, Felix M.
Abramowitz, Matthew C.
Marples, Brian
Munera, Felipe
Castillo, Rosa
Kryvenko, Oleksandr N.
Punnen, Sanoj
Stoyanova, Radka
Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title_full Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title_fullStr Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title_full_unstemmed Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title_short Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
title_sort automatic detection and quantitative dce-mri scoring of prostate cancer aggressiveness
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686056/
https://www.ncbi.nlm.nih.gov/pubmed/29177134
http://dx.doi.org/10.3389/fonc.2017.00259
work_keys_str_mv AT parranestorandres automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT pollackalan automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT chineafelixm automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT abramowitzmatthewc automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT marplesbrian automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT munerafelipe automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT castillorosa automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT kryvenkooleksandrn automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT punnensanoj automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness
AT stoyanovaradka automaticdetectionandquantitativedcemriscoringofprostatecanceraggressiveness